Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry J Kaplan

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Ocular Immunology and Inflammation|October 21, 2003
Who should pay for the new medical treatments in uveitis?Henry J Kaplan
Chemical Immunology and Allergy|February 1, 2007
Anatomy and function of the eyeHenry J Kaplan
Taiwan Journal of Ophthalmology|January 24, 2022
Innovations in retinitis pigmentosa - Metabolic rescue of cones, gene therapy, retinal transplantationHenry J Kaplan
Experimental Eye Research|December 18, 2015
Role of epithelial-mesenchymal transition in proliferative vitreoretinopathyShigeo Tamiya, Henry J Kaplan
Biomolecules|May 27, 2023
Role of Complement in the Onset of Age-Related Macular DegenerationNiloofar Piri, Henry J Kaplan
Ocular Immunology and Inflammation|March 17, 2007
Are intravitreal anti-VEGF antibodies safe?Tongalp H Tezel, Henry J Kaplan
Ocular Immunology and Inflammation|November 25, 2010
Ocular immune privilege in the year 2010: ocular immune privilege and uveitisAndrew W Taylor, Henry J Kaplan
Chemical Immunology and Allergy|February 1, 2007
Regional immunity and immune privilegeHenry J Kaplan, Jerry Y Niederkorn
Chemical Immunology and Allergy|February 1, 2007
Intraocular diseases - anterior uveitisNalini S Bora, Henry J Kaplan
Current Opinion in Allergy and Clinical Immunology|August 16, 2012
Light and ocular immunityAmir Reza Hajrasouliha, Henry J Kaplan
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Ocular Immunology and Inflammation|October 21, 2003
Who should pay for the new medical treatments in uveitis?Henry J Kaplan
Chemical Immunology and Allergy|February 1, 2007
Anatomy and function of the eyeHenry J Kaplan
Taiwan Journal of Ophthalmology|January 24, 2022
Innovations in retinitis pigmentosa - Metabolic rescue of cones, gene therapy, retinal transplantationHenry J Kaplan
Experimental Eye Research|December 18, 2015
Role of epithelial-mesenchymal transition in proliferative vitreoretinopathyShigeo Tamiya, Henry J Kaplan
Biomolecules|May 27, 2023
Role of Complement in the Onset of Age-Related Macular DegenerationNiloofar Piri, Henry J Kaplan
Ocular Immunology and Inflammation|March 17, 2007
Are intravitreal anti-VEGF antibodies safe?Tongalp H Tezel, Henry J Kaplan
Ocular Immunology and Inflammation|November 25, 2010
Ocular immune privilege in the year 2010: ocular immune privilege and uveitisAndrew W Taylor, Henry J Kaplan
Chemical Immunology and Allergy|February 1, 2007
Regional immunity and immune privilegeHenry J Kaplan, Jerry Y Niederkorn
Chemical Immunology and Allergy|February 1, 2007
Intraocular diseases - anterior uveitisNalini S Bora, Henry J Kaplan
Current Opinion in Allergy and Clinical Immunology|August 16, 2012
Light and ocular immunityAmir Reza Hajrasouliha, Henry J Kaplan
Pageof 20